BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26389674)

  • 1. IL-34 is a Treg-specific cytokine and mediates transplant tolerance.
    Bézie S; Picarda E; Ossart J; Tesson L; Usal C; Renaudin K; Anegon I; Guillonneau C
    J Clin Invest; 2015 Oct; 125(10):3952-64. PubMed ID: 26389674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance.
    Li XL; Ménoret S; Bezie S; Caron L; Chabannes D; Hill M; Halary F; Angin M; Heslan M; Usal C; Liang L; Guillonneau C; Le Mauff B; Cuturi MC; Josien R; Anegon I
    J Immunol; 2010 Jul; 185(2):823-33. PubMed ID: 20543104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.
    Abe Y; Urakami H; Ostanin D; Zibari G; Hayashida T; Kitagawa Y; Grisham MB
    PLoS One; 2009 Nov; 4(11):e7840. PubMed ID: 19956764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CD8+ T cell-derived CD40 signals is necessary but not sufficient for Foxp3+ induced regulatory T cell generation in vivo.
    Liu D; Ferrer IR; Konomos M; Ford ML
    J Immunol; 2013 Aug; 191(4):1957-64. PubMed ID: 23858029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.
    Turnquist HR; Zhao Z; Rosborough BR; Liu Q; Castellaneta A; Isse K; Wang Z; Lang M; Stolz DB; Zheng XX; Demetris AJ; Liew FY; Wood KJ; Thomson AW
    J Immunol; 2011 Nov; 187(9):4598-610. PubMed ID: 21949025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-34 deficiency impairs FOXP3
    Freuchet A; Salama A; Bézie S; Tesson L; Rémy S; Humeau R; Règue H; Sérazin C; Flippe L; Peterson P; Vimond N; Usal C; Ménoret S; Heslan JM; Duteille F; Blanchard F; Giral M; Colonna M; Anegon I; Guillonneau C
    Clin Transl Med; 2022 Aug; 12(8):e988. PubMed ID: 36030499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory Regulatory Networks between CD8 T, B, and Myeloid Cells in Organ Transplantation Tolerance.
    Bézie S; Picarda E; Ossart J; Martinet B; Anegon I; Guillonneau C
    J Immunol; 2015 Dec; 195(12):5805-15. PubMed ID: 26553075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines affecting CD4
    Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
    Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection.
    Picarda E; Bézie S; Venturi V; Echasserieau K; Mérieau E; Delhumeau A; Renaudin K; Brouard S; Bernardeau K; Anegon I; Guillonneau C
    J Clin Invest; 2014 Jun; 124(6):2497-512. PubMed ID: 24789907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant tolerance: a new role for IL-34.
    Kim JI; Turka LA
    J Clin Invest; 2015 Oct; 125(10):3751-3. PubMed ID: 26389671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice.
    Guo H; Wang W; Zhao N; He X; Zhu L; Jiang X
    Transpl Immunol; 2013 Dec; 29(1-4):99-104. PubMed ID: 24103733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells.
    Picarda E; Bézie S; Boucault L; Autrusseau E; Kilens S; Meistermann D; Martinet B; Daguin V; Donnart A; Charpentier E; David L; Anegon I; Guillonneau C
    JCI Insight; 2017 Feb; 2(3):e90088. PubMed ID: 28194440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-34 Actions on FOXP3
    Bézie S; Freuchet A; Sérazin C; Salama A; Vimond N; Anegon I; Guillonneau C
    Front Immunol; 2020; 11():1496. PubMed ID: 32849510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-25 promotes the function of CD4+CD25+ T regulatory cells and prolongs skin-graft survival in murine models.
    Tang J; Zhou X; Liu J; Meng Q; Han Y; Wang Z; Fan H; Liu Z
    Int Immunopharmacol; 2015 Oct; 28(2):931-7. PubMed ID: 25864622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.
    Conde P; Rodriguez M; van der Touw W; Jimenez A; Burns M; Miller J; Brahmachary M; Chen HM; Boros P; Rausell-Palamos F; Yun TJ; Riquelme P; Rastrojo A; Aguado B; Stein-Streilein J; Tanaka M; Zhou L; Zhang J; Lowary TL; Ginhoux F; Park CG; Cheong C; Brody J; Turley SJ; Lira SA; Bronte V; Gordon S; Heeger PS; Merad M; Hutchinson J; Chen SH; Ochando J
    Immunity; 2015 Jun; 42(6):1143-58. PubMed ID: 26070485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
    J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
    Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
    Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.